Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ALBERTDAVD Albert David Limited Pharma · Small | HALEOSLABS HALEOS LABS LIMITED Pharma · Small | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | AMANTA Amanta Healthcare Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 23 | 29 | 15 | 44 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Piotroski | 3/9 | 8/9 | 6/9 | 6/9 |
| Valuation | 5/30 | 7/30 | 3/30 | 9/30 |
| Growth | 7/25 | 8/25 | 2/25 | 21/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 9/15 | 6/15 | 7/15 |
| Cash Flow | 3/10 | 3/10 | 4/10 | 4/10 |
| Price | ₹710 | ₹1,407.9 | ₹80.24 | ₹135.46 |
| P/E | — | 23.70 | 55.60 | 31.80 |
| P/B | 1.01 | 1.92 | 1.47 | 2.38 |
| ROE | -0.38% | 8.44% | 2.75% | 10.40% |
| ROCE | 0.77% | 9.91% | 5.58% | 11.60% |
| Debt / Equity | 0.08 | 0.52 | 0.33 | 1.11 |
| FCF Yield | — | — | — | — |
| Dividend Y | 0.72% | 0.11% | — | — |
| Altman Z | 3.86 | 2.91 | 3.33 | 2.40 |
| Promoter % | 62.23% | 72.10% | 37.71% | 63.72% |
| Mkt Cap (₹Cr) | 396.00 | 410.00 | 221.00 | 523.00 |
| Graham # | — | ₹953.72 | ₹40.86 | ₹69.9 |
| Fair PE | 23.5 | 13.8 | 4.2 | 42.0 |
| MoS % | — | -77.9% | -1261.3% | +15.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startALBERTDAVD50
HALEOSLABS101
AAREYDRUGS125
AMANTA97